Cannabis Report
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

$6.6 million 4th Qtr 2017 Tight Estimate

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
tilator Member Profile
 
Followed By 0
Posts 516
Boards Moderated 0
Alias Born 09/14/17
160x600 placeholder
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 7/19/2018 6:04:44 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/16/2018 5:08:06 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/13/2018 5:16:17 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/11/2018 4:44:38 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/8/2018 5:27:56 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/22/2018 4:10:49 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/16/2018 8:07:08 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/8/2018 8:06:14 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/27/2018 8:10:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/23/2018 5:17:20 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/16/2018 5:16:42 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/16/2018 5:10:45 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/3/2018 5:13:01 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/29/2018 6:13:48 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/22/2018 6:07:41 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/21/2018 4:38:55 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/21/2018 6:10:39 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/20/2018 5:12:58 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/20/2018 4:37:22 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/20/2018 6:08:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/20/2018 6:08:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2018 3:05:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/19/2018 6:10:42 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/16/2018 6:14:56 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/16/2018 6:14:55 AM
tilator   Friday, 11/10/17 05:12:56 PM
Re: AngeloFoca post# 31212
Post # of 35915 
Quote:
$6.6 million 4th Qtr 2017 Tight Estimate



You are right, but the big question is why on earth MNK can sell only 1-2% compared to Accord and Lupin sales even though they got approval together?

This leaves much to gain to MNK.

If MNK got 1000% growth right now, it still would sell only 10% compared to Accord and 20% compared to Lupin.

Well - the numbers are prescription counts, not dollars, but anyway. I suppose you got the point.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist